Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that play a critical role in initiating and regulating adaptive immune responses. They capture, process, and present antigens on MHC molecules to T cells, leading to T cell activation, differentiation, and effector functions. DCs are crucial for both immunity and tolerance, and are therefore key targets for immunotherapies against cancer, infectious diseases, and autoimmune disorders.
Antigen processing and presentation via MHC class I and II molecules leading to T cell receptor engagement and T cell activation or tolerance.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic Cell Antigen-Presenting Function (DC Antigen Presentation).